ARCC vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARCC's Piotroski F-Score of 2/9 indicates severe financial distress, signaling weak operational and accounting health. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given a high debt/equity ratio of 1.12 and a current ratio of 0.56. Despite a high dividend yield of 10.75%, the payout ratio exceeds 100% (103.23%), making the dividend unsustainable in the long term. The stock trades at a P/E of 9.60, below the sector average, but this is misleading due to a sharp 24.9% YoY earnings decline and negative earnings growth. The technical trend is bearish, and insider activity is neutral, offering no confidence in leadership's conviction.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ARCC vs JPM: Head-to-Head Comparison
This page compares Ares Capital Corporation (ARCC) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.